Skip to main content

Table 1 Baseline characteristics and results

From: Altered sphingoid base profiles in type 1 compared to type 2 diabetes

 

Type 1

Type 2

Control

overall p-value

T1 vs. T2 p-value

T2 vs. control p-value

T1 vs. control p-value

N

27

30

23

Kruskal-Wallis/Chi-Sq

Wilcoxon/Fisher’s

Wilcoxon/Fisher’s

Wilcoxon/Fisher’s

Age, mean (s.d.)

47 (14.6)

60 (13.6)

43 (15)

<0.001

0.001

<0.001

0.4

Male, N (%)

16 (59)

16 (53)

11 (48)

0.7

0.8

0.8

0.6

HbA1c, mean (s.d.)

7.3 (1.3)

7.8 (2)

5.2 (0.3)

<0.001

0.4

<0.001

<0.001

TG, mean (s.d.)

70 (33)

145 (84)

84 (35)

<0.001

<0.001

0.003

0.1

LDL, mean (s.d.)

87 (27)

83 (35)

116 (44)

0.006

0.8

0.008

0.006

HDL, mean (s.d.)

70 (17)

49 (22)

60 (19)

<0.001

<0.001

0.02

0.04

HTN, N (%)

14 (52)

25 (83)

3 (13)

<0.001

0.02

<0.001

0.006

SBP, mean (s.d.)

124 (15)

130 (15)

125 (17)

0.2

0.08

0.3

0.8

DBP, mean (s.d.)

72 (8)

74 (8)

76 (12)

0.4

0.4

0.7

0.2

Cr, mean (s.d.)

0.97 (0.4)

0.90 (0.2)

0.91 (0.5)

0.2

0.7

0.2

0.07

Statin, N (%)

14 (52)

23 (77)

2 (9)

<0.001

0.06

<0.001

0.002

DM duration, mean (s.d.)

25 (11)

13 (8)

0

 

<0.001

  

C16SO, mean (s.d.)

16.9 (4.4)

18.4 (6.0)

19.9 (9.5)

0.8

0.5

0.99

0.6

C16SA, mean (s.d.)

0.26 (0.13)

0.41 (0.19)

0.45 (0.22)

<0.001

<0.001

0.6

0.001

C17SO, mean (s.d.)

7.1 (1.6)

7.4 (2.3)

8.5 (3.3)

0.5

0.8

0.4

0.3

C18SAdiene, mean (s.d.)

34.9 (6.4)

30.3 (9.3)

39.3 (11.3)

0.007

0.02

0.006

0.3

C18SO, mean (s.d.)

92.3 (11.2)

87.1 (20.4)

103.9 (25.4)

0.02

0.1

0.01

0.1

C18SA, mean (s.d.)

3.1 (1.0)

2.4 (0.6)

2.9 (1.0)

0.01

0.03

0.3

0.008

C20SO, mean (s.d.)

0.13 (0.02)

0.15 (0.05)

0.14 (0.04)

0.2

0.06

0.2

0.8

C20SA, mean (s.d.)

0.02 (0.004)

0.02 (0.01)

0.02 (0.002)

0.02

0.004

0.3

0.1

doxSA, mean (s.d.)

0.05 (0.02)

0.09 (0.06)

0.05 (0.02)

<0.001

<0.001

<0.001

0.5

doxSO, mean (s.d.)

0.12 (0.04)

0.19 (0.11)

0.12 (0.04)

0.002

0.002

0.006

0.9